Akemi Kosaka

Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma

Laura A. Johnson, John Scholler, Takayuki Ohkuri et al. · Science Translational Medicine · 2015 · 448 citations · Full text

STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment

Takayuki Ohkuri, Arundhati Ghosh, Akemi Kosaka et al. · Cancer Immunology Research · 2014 · 253 citations · Full text

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

Takayuki Ohkuri, Akemi Kosaka, Kei Ishibashi et al. · Cancer Immunology Immunotherapy · 2017 · 202 citations · Full text

Inflammation, Intratumoral Administration, Cytokine +12

Double-Stranded RNA of Intestinal Commensal but Not Pathogenic Bacteria Triggers Production of Protective Interferon-β

Tadaomi Kawashima, Akemi Kosaka, Huimin Yan et al. · Immunity · 2013 · 201 citations · Full text

Intestinal Commensal, Dysbiosis, Mucosal Immunology +12

Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy

Toshihiro Nagato, Takayuki Ohkuri, Kenzo Ohara et al. · Cancer Immunology Immunotherapy · 2017 · 158 citations · Full text

Lymphoid Neoplasia, Autoimmune Disease, Soluble Form +10